10-Q · May 14, 2026
AXT, Inc. reported Q1 2026 revenue of $26.9 million, a 39.1% increase year-over-year, driven primarily by demand for InP wafer substrates. The company narrowed its EPS loss to -$0.03 from -$0.20 in the prior year,…
Earnings analysis · 10-Q
Filed August 13, 2026 · Our reading of the company's report
The latest report
AXT delivered a sharp Q2 rebound, with revenue of $47.589 million versus $27 million in Q1 2026 and $18 million in Q2 2025, while diluted EPS improved to $0.19 from losses in both comparison periods. The principal…
AXT delivered a sharp Q2 rebound, with revenue of $47.589 million versus $27 million in Q1 2026 and $18 million in Q2 2025, while diluted EPS improved to $0.19 from losses in both comparison periods. The principal financial overhang is the approximately $49 million Tongmei redemption exposure following withdrawal of its IPO application. Export-permit uncertainty, expanded PRC trade-control authority and ongoing litigation remain material risks, although management states that it has sufficient funds to satisfy a full redemption and that disclosure controls were effective.
Q2 2026 revenue was $47.589 million, up from $27 million in Q1 2026 and $18 million in Q2 2025, while diluted EPS improved to $0.19 from $(0.03) and $(0.16), respectively.
The company stated that it has sufficient funds to redeem the Tongmei investors' interests in full if required; the aggregate redemption amount is approximately $49 million.
Minority investments in Chinese raw-material companies totaled $14.1 million at June 30, 2026, compared with $15.0 million at December 31, 2025, a $0.9 million reduction.
No customer represented more than 10% of accounts receivable at June 30, 2026, compared with one customer above 10% at December 31, 2025, indicating lower receivables concentration.
Management concluded that disclosure controls and procedures were effective at the reasonable-assurance level as of June 30, 2026, and reported no material changes in internal control during the quarter.
North American sales represented approximately 2% of 2025 revenue versus 8% in 2024, while tariffs paid declined to approximately $0.3 million in 2025 from $1.0 million in both 2024 and 2023.
Tongmei's July 8, 2026 IPO withdrawal triggered redemption rights for investors. The aggregate redemption amount is approximately $49 million, and the U.S.-dollar payment will vary with the RMB/USD exchange rate.
All wafer substrates are manufactured in China, and three wafer-substrate product families require Ministry of Commerce permits before export. InP permits remain uncertain, while no permits for gallium arsenide exports to U.S. customers had been approved as of the report.
The revised Foreign Trade Law became effective March 1, 2026 and gives Chinese agencies enhanced power to restrict imports and exports. The filing states that additional restrictions cannot be ruled out.
The shareholder class action was dismissed twice but received leave to amend; the plaintiff filed a third amended complaint on August 4, 2026. The company states that the ultimate outcome and any loss range cannot currently be estimated.
The company recorded foreign-exchange losses of $74,000 in 2025 after gains of $91,000 in 2024 and $169,000 in 2023. Its hedging program primarily covers Japanese yen and may not fully mitigate currency exposure.
Management disclosed gross margin volatility from product mix, yields, utilization, raw-material costs and tariffs; historical gross margin ranged from negative 6.4% in Q1 2025 to 22.3% in Q3 2025.
No numeric revenue or EPS outlook was provided in the extracted 10-Q; the filing refers generally to public guidance but does not state quantitative quarterly guidance.
AXT, Inc. reported Q1 2026 revenue of $26.9 million, a 39.1% increase year-over-year, driven primarily by demand for InP wafer substrates. The company narrowed its EPS loss to -$0.03 from -$0.20 in the prior year,…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.